Page 1,345«..1020..1,3441,3451,3461,347..1,3501,360..»

FAQs – Stem Cell Therapy for Osteoarthritis | SCRC

Posted: December 7, 2018 at 3:45 pm

Stem Cell Therapy for Osteoarthritis

New treatments and advances in research are giving new hope to people affected by Osteoarthritis pain and symptoms. Stem Cell Research Centre provides stem cell therapy for Osteoarthritis to help those with unmet clinical needs achieve optimum health and better quality of life.

Stem cell therapy for Osteoarthritis is being studied for efficacy in improving the complications in patients through the use of their own stem cells. These procedures may help patients who dont respond to typical drug treatment, want to reduce their reliance on medication, or are looking to try stem cell therapy before starting drug treatment.

To learn more about becoming a patient and receiving stem cell therapy for Osteoarthritis through Stem Cell Research Centre, please contact one of our patient advocates at (800) 609-7795 or fill out the contact form on this page.Below are some frequently asked questions about stem cell treatment for Osteoarthritis.

The majority of complications in Osteoarthritis patients are related to the deterioration of cartilage that cushions the ends of bones in your joints. Cartilage is a firm, slippery tissue that permits nearly frictionless joint motion. In Osteoarthritis, this surface become rough. Eventually, if the cartilage wears down completely, patients will be left with bone rubbing on bone.

Stem cell treatment provided by Stem Cell Research Centre is designed to target these areas within the joints to help with the creation of new cartilage cells. Mesenchymal stem cells are multipotent and have the ability to differentiate into cartilage called (chondrytes). The goal of each stem cell treatment is to inject the stem cells into the joint to create cartilage (chondryte cells). Stem cells are a natural anti-inflammatories which can assist with Osteoarthritis pain and swelling in the joint area.

Stem cells are the basic building blocks of human tissue and have the ability to repair, rebuild, and rejuvenate tissues in the body. When a disease or injury strikes, stem cells respond to specific signals and set about to facilitate the healing process by differentiating into specialized cells required for the bodys repair.

There are four known types of stem cells which include:

Stem Cell Research Centre provides autologous adult stem cells (from fat tissue) where the stem cells come from the person receiving treatment.

Stem Cell Research Centre provides autologous adult adipose-derived stem cells (from fat tissue) where the stem cells come from the person receiving treatment.

We tap into our bodys stem cell reserve daily to repair and replace damaged or diseased tissue. When the bodys reserve is limited and as it becomes depleted, the regenerative power of our body decreases and we succumb to disease and injury.

Three sources of stem cells from a patients body are used clinically which include adipose tissue (fat), bone marrow and peripheral blood.

Performed by Board Certified Physicians, dormant stem cells are extracted from the patients adipose tissue (fat) through a minimally invasive mini-liposuction procedure with little to no downtime.

During the liposuction procedure, a small area (typically the abdomen) is numbed with an anesthetic and patients receive mild to moderate sedation. Next, the extracted dormant stem cells are isolated from the fat and activated, and then comfortably infused back into the patient intravenously (IV) and via other directly targeted methods of administration. The out-patient procedure takes approximately four to five hours.

Stem Cell Research Centre provides multiple administration methods for Osteoarthritis patients to best target the disease related conditions and symptoms which include:

Since each condition and patient are unique, there is no guarantee of what results will be achieved or how quickly they may be observed. According to patient feedback, many patients report results in one to three months, however, it may take as long as six to nine months. Individuals interested in stem cell therapy are urged to consult with their physician before choosing investigational autologous adipose-derived stem cell therapy as a treatment option.

In order to determine if you are a good candidate for adult stem cell treatment, you will need to complete a medical history form which will be provided by your Stem Cell Research Centre Patient Advocate. Once you complete and submit your medical history form, our medical team will review your records and determine if you are a qualified candidate for adult stem cell therapy.

Stem Cell Research Centre team members are here to help assist and guide you through the patient process.

Patients travel to Stem Cell Research Centre treatment center located in San Diego, California for stem cell treatment from all over the United States, Canada and around the globe. Treatment will consist of one visit lasting a total of three days. The therapy is minimally invasive and there is little to no down time. Majority of patients fly home the day after treatment.

We provide stem cell therapy for a wide variety of diseases and conditions for which traditional treatment offers less than optimal options. Some conditions include Multiple Sclerosis, Parkinson's Disease, Rheumatoid Arthritis, Osteoarthritis and Chronic Obstructive Pulmonary Disease (COPD).

The side effects of the mini-liposuction procedure are minimal and may include but are not limited to: minor swelling, bruising and redness at the procedure site, minor fever, headache, or nausea. However, these side effects typically last no longer than 24 hours and are experienced mostly by people with sensitivity to mild anesthesia. No long-term negative side effects or risks have been reported.

The side effects of adipose-derived stem cell therapy are minimal and may include but are not limited to: infection, minor bleeding at the treatment sites and localized pain. However, these side effects typically last no longer than 24 hours. No long-term negative side effects or risks have been reported.

Stem Cell Research Centre provides adult stem cell treatment with mesenchymal stem cells which come from the person receiving treatment. Embryonic stem cells are typically associated with ethical and political controversies.

Stem cell treatment is not FDA approved.

Stem cell for arthritis treatment is not covered by health insurance at this time. The cost for standard preoperative labs are included. Additional specific labs may be requested at the patients expense.

Osteoarthritis, or degenerative joint disease, is the most common type of arthritis. It is caused by the degradation of a joints cartilage. Cartilage is a firm, rubbery material that covers and cushions the ends of bones in normal joints. Its main function is to reduce friction in the joints and serve as an intermediary or cushion.

Over time, the cartilage may wear away in some areas, greatly decreasing its ability to act as a shock absorber. As the cartilage wears away, tendons and ligaments stretch, causing pain. In advanced cases, the bones could rub against each other, causing even more pain and loss of movement.

Osteoarthritis is very common in middle-aged and older people, and its symptoms can range from very mild to very severe. The disorder most often affects hands and weight-bearing joints such as knees, hips, feet and shoulders, but can affect almost any joint in the body.

More:
FAQs - Stem Cell Therapy for Osteoarthritis | SCRC

Posted in Stem Cell Therapy | Comments Off on FAQs – Stem Cell Therapy for Osteoarthritis | SCRC

Stem Cell Therapy – Top Rated Local Stem Cell Treatment In …

Posted: December 7, 2018 at 3:45 pm

What are stem cells?

Stem cells are the basic building blocks of human tissue and have the ability to repair, rebuild, and rejuvenate tissues in the body. When a disease or injury strikes, stem cells respond to specific signals and set about to facilitate the healing process by stimulating your own body to repair itself.

Stem cells that come from perinatal tissue(healthy post-natal C-sections) have distinct functional properties including immunomodulation and anti-inflammation which support the repair and regeneration of damaged tissue associated with disease and injury.

There are four known types of stem cells which include:

We provide allogeneic regenerative cytokines and mesenchymal stem cells from health post-natal C-sections.

We tap into our bodys stem cell reserve daily to repair and replace damaged or diseased tissue. When the bodys reserve is limited and as it becomes depleted, the regenerative power of our body decreases and we succumb to disease and injury.

Three sources of stem cells from a patients body are used clinically which include adipose tissue (fat), bone marrow and umbilical cord matrix(Whartons Jelly).

We provide stem cell therapy for a wide variety of musculoskeletal conditions for which traditional treatment offers less than optimal options. Some conditions include Osteoarthritis, Bursitis, Plantar Fasciitis and Degenerative Disc Disease

Since each condition and patient are unique, there is no guarantee of what results will be achieved or how quickly they may be observed. According to patient feedback, many patients report results in one to three months, however, it may take as long as six to nine months. Individuals interested in stem cell therapy are urged to consult with their physician before choosing investigational allogeneic umbilical cord derived regenerative medicine allografts as a treatment option.

In order to determine if you are a good candidate for a regenerative medicine treatment, you will need to complete a medical history form which will be provided by our patient advocate team. Once you complete and submit your medical history form, our medical team will review your records and determine if you are a qualified candidate for a regenerative medicine therapy.

The side effects of intra-articular injection of a regenerative medicine allograft are minimal and may include but are not limited to: infection, minor bleeding at the treatment sites and localized pain. However, these side effects typically last no longer than 24 hours.

We provide regenerative medicine allografts from healthy post-natal C-section births that provide regenerative factors and mesenchymal stem cells. Embryonic stem cells are typically associated with ethical concerns. We do not offer embryonic stem cells.

Our regenerative medicine allografts are regulated as human cell and tissue transplants, similar to skin and bone. As structural human cell and tissue products regulated under FDA CFR 1271 Part 361, our allografts do not require FDA approval, rather we are strictly regulated to prevent the spread of communicable diseases and to maintain the structural integrity of the allografts as theyre harvested from umbilical cords and transferred for musculoskeletal cushioning, protection and supplementation. These regenerative allografts are FDA regulated rather than FDA approved. The FDA is a regulatory oversight body and doesnt exercise legal authority. If an FDA regulated tissue transplant or therapy is noted as non-compliant and not corrected according to FDA guidelines, the FDA may refer a significant public health risk to the Department of Justice or a state attorney general.

Stem cell treatment is not covered by health insurance at this time.

Although stem cells are found throughout our bodies, mesenchymal stem cells can only be harvested for native (non-cultured) use from adipose, bone marrow and umbilical cord matrix. The term amniotic stem cells is an oxymoron in that amniotic fluid and matrix products dont contain stem cells. They do however contain unique cytokines and other growth factors.

Read the original post:
Stem Cell Therapy - Top Rated Local Stem Cell Treatment In ...

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy – Top Rated Local Stem Cell Treatment In …

Stem Cell Therapy – Dr Sobo, Stamford CT

Posted: December 7, 2018 at 3:45 pm

The Stem Cell Procedure

Optimal Health Medical, LLC uses adult autologous stem cells, meaning that they are derived and taken from your own body, which avoids the possibility of rejection. A simple in-office procedure a called a bone marrow aspiration is performed to obtain your own stem cells.

HOW IS BONE MARROW ASPIRATION PERFORMED?

Bone marrow is extracted from the back of a patients pelvis called the posterior iliac crest.

The doctor will inject a local anesthetic (numbing agent), to prevent discomfort and pain. Bone Marrow aspiration involves one small incision in the skin to introduce the bone marrow needle for aspiration. You may experience some discomfort during the procedure, but it is brief, and if needed more local anesthesia will be provided.

HOW LONG IS THE PROCEDURE?

The actual extraction takes just a couple of 2 minutes. The full procedure and visit will take up to a couple of hours. During that time the handling of the bone marrow sample will include separating the red blood cells, and placing the sample in a centrifuge for its final preparation for injection back into the body.

Utilizing the most advanced technique for stem cell injection, the doctor will perform what is called a Guided Stem Cell Injection. Guided injection stem cell treatments are done by the doctor using a portable ultrasound machine, positioned to allow the doctor to see the needle as he guides it to the area to be injected.

IS THE PROCEDURE SAFE?

Bone marrow aspirations are safe when properly performed in a sterile environment. Complications are rare but can include:

The risks of a bone marrow aspirate include the following: pain or temporary discomfort and/or bruise at the site of the puncture. Post-procedure treatment guidelines will be provided in the initial consultation.

HOW LONG IS THE RECOVERY TIME?

Most patients are able to return to basic daily activities in 3 days but some pain may be felt at the aspiration site for up to 1 week. Return to exercise or sports or which place on the joint may take several weeks, and guided by the doctor on an individualized basis.

Read more:
Stem Cell Therapy - Dr Sobo, Stamford CT

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy – Dr Sobo, Stamford CT

Stem Cell Therapy for Anti-Aging and Sexual Performance …

Posted: December 7, 2018 at 3:45 pm

Stem Cell Therapy has been around for quite some time, but due to high cost it was primarily used for recovery in athletes and the financial elite. However, with the progression of science and knowledge, stem cell therapy has become much more widely used and financially attainable.

Tampa Rejuvenation is the first in Tampa Bay to utilize the benefits of stem cell therapy for the purpose of anti-aging and sexual performance. We realize as our patients age, their bodies no longer have the regenerative properties to attain the desired results from using their growth factors alone as with our PRP, or Plasma Rich Platelet, therapy. Although many patients will still yield improvement with the PRP alone, the magnitude of cytokines and growth factors in your blood as you age will deplete with age. By implementing stem cell therapy, the number of growth factors are exponential allowing our bodies to regenerate on a magnitude that is otherwise unattainable with some results lasting for 3-5 years.

Stem Cell Therapy can be used to restore vitality to the skin, encourage the growth of hair, and even restore sexual performance and pleasure.

View original post here:
Stem Cell Therapy for Anti-Aging and Sexual Performance ...

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy for Anti-Aging and Sexual Performance …

15 Stem Cell Therapy For Pain Questions, Answered

Posted: December 7, 2018 at 3:45 pm

Stem cell therapy is an exciting area of research that holds tremendous potential for helping chronic pain patients reduce their pain. Rapid advances in this field of medicine are buoying doctors and patients hopes that the exciting therapy could change lives. Advances are being made nearly every day, and as scientists further understand the nature of these cells, even more uses for them are becoming known. If youve ever wondered about how stem cell therapy for pain could help you, these 15 questions delve into how this therapy works and who it could be used for.

Science has a strong interest in stem cells because of their renewing properties and the ability of these cells to develop into any type of tissue in the body of the organism. Researchers believe that they have the potential for immeasurable clinical uses in health. Research is advancing many stem cell based therapies for people who suffer from diseases such as:

Mayo Clinic explains how this therapy works:

Stem cell therapy, also known as regenerative medicine, promotes the reparative response of diseased, dysfunctional or injured tissue using stem cells or their derivativesResearchers grow stem cells in a lab. These stem cells are manipulated to specialize into specific types of cells, such as heart muscle cells, blood cells or nerve cells. The specialized cells can then be implanted into a person.

Stem cell therapy is actually a type of treatment within the larger umbrella of regenerative medicine. Our longer post on regenerative medicine discusses the types of treatments available, including stem cell therapy and platelet-rich plasma injections.

Stem cells are essentially blank canvases that can transform into any type of cell in the human body. Specialized cells like bone cells, liver cells, and heart cells begin as stem cells. The process of the cells transforming from blank slates into specialized cells is called differentiation.

Stem cell therapy is the process of injecting these cells into damaged areas of the body, such as arthritic knees or shoulders. The stem cells then differentiate into damaged tissue, helping to regenerate the entire area.

There are two different types of natural stem cells and one that is genetically reprogrammed within the laboratory. Embryonic stem cells are the most immature and are found within the early stages of a growing embryo, usually after it has been left to develop five to six days. After the egg and sperm have united, the fertilized egg divides and creates stem cells that differentiate into the specialized cells the body requires to function. Many techniques using stem cells for pain therapies no longer rely on these types of stem cells.

The second type of stem cell, found naturally in organisms, is adult stem cells. These are present in developed tissue, such as muscle, skin, bone, brain, and blood. Also called tissue stem cells, they can self-renew and generate one specialized cell type. Under normal circumstances these tissue stem cells, or adult stem cells, will generate the type of cells that make up the organ in which they reside. These cells are used by the body to divide and repair injured areas or regenerate into specialized cells to replace the ones that are dead or damaged.

The third type of stem cells, which are genetically reprogrammed in the laboratory, are induced pluripotent stem cells. After years of stem cell research and development, it was discovered that artificially triggering certain genetic components would prompt different cells to become pluripotent stem cells, which were similar in nature to embryonic stem cells. This helps avoid ethical concerns associated with using human embryonic tissue for research and regenerative medicine.

The following video from an Arizona pain doctor goes into detail about how stem cell therapy for pain works.

There are twomajor types of stem cells: those harvested from adults and those harvested from embryonic tissues.

However, there are other ways to retrieve stem cells that reduce the use of embryonic stem cells, including:

As the Euro Stem Cell organization reports, some of these types of stem cells are more effective than others.

One source of stem cells is human embryos. These cells are called pluripotent stem cells, and theyre very useful to researchers because they can be multiplied indefinitely in the laboratory. Although these cells are often cultivated from embryos that are just a few days old, they can also be taken from fetal tissue thats older than eight weeks, according to the National Institutes of Health (NIH).

The majority of therapeutic stem cells come from adults. Even though embryos are the richest source of stem cells, humans of all ages have stem cells. Stem cells give adults the ability to replace damaged tissue, heal wounds, and grow hair.The patients own adult stem cells are extracted, purified, concentrated, and then injected into the damaged tissue. This process is usually non-surgical and the individual has very little recovery time. Most patients report only some soreness around the site of the injection. Sometimes there is also slight bruising. There have been no reports of serious side effects from treatments using stem cell therapy.

Newer research has given scientists the ability to reprogram specialized adult cells so they essentially return to their original stem cell state. These reprogrammed cells are known as induced pluripotent stem cells. Although this ability exists, scientists arent sure how or if these artificially created stem cells behave differently than other types.

Despite these unknowns, the reprogrammed stem cells are already being used in the development of medicines and helping scientists learn more about specific types of diseases, according to NIH.

Stem cells have many uses, and the full spectrum of their application isnt yet known. One way stem cells are helping researchers is by illuminating the inner workings of various diseases. Stem cells offer scientists the ability to model human disease progression in a laboratory setting.

This is exciting because many studies rely on animals with similar, but not exact, biology to humans. The more scientists can understand about human-specific disease progression, the greater insight they have regarding potential treatments.

For example, one of the earliest uses for stem cells were bone marrow transplants, used to help patients with leukemia or sickle cell anemia heal. This treatment has been used for more than 40 years. In addition, stem cell therapy may be used to treat:

The application of most interest to chronicpatients is likely the emerging field of regenerative medicine, which is the science of helping tissues regenerate. This field examines the potential of stem cells to repair damaged tissue and heal areas of the body bone and potentially organs, too affected by arthritis, diabetes, spinal cord injuries, nerve damage, Parkinsons disease, and more.

Exciting research has also uncovered the potential for stem cells to expand the number of lungs available for transplant. A portion of lungs available for transplant arent used because they become damaged. However, research from the American Physiological Society has found stem cells could help repair the organs and prepare them to save lives.

Other recent researchstories include:

For many of the studies underway, time is needed to fully examine the benefits and potential dangers of this treatment. Another obstacle is obtaining specific types of adult stem cells. Theyre difficult to grow in the laboratory, making it hard to produce the large numbers available for research.

Another potential issue with donor stem cells is the possibility of rejection. The immune system of the recipient could reject the cells, essentially making it difficult for the treatment to work as intended and causing ancillary problems.

Finally, since this is such a new treatment area, some government agencies are calling for more oversight of its use. Others are pushing back, claiming that stem cell therapy provides a new area of treatment for patients who have exhausted all other options.

That being said, even though there are complications and roadblocks to its use, the benefits of stem cell therapy could be huge. As the American Academy of Anti-Aging Medicine notes:

[A]n analysis of the potential benefits of stem cells based therapies indicates that 128 million people in the United States alone may benefit with the largest impact on patients with Cardiovascular disorders (5.5 million), autoimmune disorders (35 million) and diabetes (16 million US patients and more than 217 million worldwide).

Californias Stem Cell Agency gives a great overview of this process, noting:

In order to be approved by the FDA for use in human trials, stem cells must be grown in good manufacturing practice (GMP) conditions. Under GMP standards, a cell line has to be manufactured so that each group of cells is grown in an identical, repeatable, sterile environment. This ensures that each batch of cells has the same properties, and each person getting a stem cell therapy gets an equivalent treatment. Although the FDA hasnt yet issued guidelines for how pluripotent stem cells need to meet GMP standards, achieving this level of consistency could mean knowing the exact identity and quantity of every component involved in growing the cells.

Stem cell therapy is being studied for a number of chronic pain conditions, especiallypain in the:

Stem cell therapy for pain could help reduce the inflammation that results in chronic pain, or it could help to heal regenerative conditions that lead to pain, such as arthritis.

Using stem cell therapy for knee pain is one of the leading areas of research. Stem cell therapy for knees can be provided as stem cell injections or as blood platelet treatments from the body itself (another form of regenerative medicine).These two treatments may help relieve pain associated with:

The leading researchers on stem cell therapy for knee pain claim that it can help patients avoid surgery, with its associated costs and risks.

Since stem cell therapy promises to treat a number of conditions related to degenerative conditions, like arthritis and tendonitis, stem cell therapy may present a great treat option for hip pain related to these causes.

The National Multiple Sclerosis Society is leading the efforts in research, but currently reports the following:

At present, there are no approved stem cell therapies for MS. Larger, longer-term, controlled studies are needed to determine the safety and effectiveness of using stem cells to treat MS. When the results of these and subsequent clinical trials are available, it should be possible to determine what the optimal cells, delivery methods, safety and actual effectiveness of these current experimental therapies might be for different people with MS.

Potentially. One of our sister clinics, Arizona Pain, is participating in a study evaluating the potential of stem cells to reduce back pain related to degenerative disc disease. This progressive condition sometimes results from injury, but other times has no clear cause.

The study is exciting because it involves stem cells harvested from the bone marrow of healthy, young adults, and therefore itdoesnt come with the ethical concerns of embryonic stem cells. So far, the results have been very positive, and a significant number of people who received stem cells for their back pain have experienced reduced discomfort and improved quality of life.

This study is currently in Phase III, which is the phase immediately preceding potential FDA approval. This means it could soon be available to many more patients and potentially covered by insurance, although each insurance companys coverage policy varies.

Absolutely, and the research into this area is very promising. In fact, scientists have recently uncovered the specific type of stem cell most likely to reduce arthritis pain. Theyre special cells that are specifically able to rebuild tissue, bone, and cartilage, potentially offering much relief to osteoarthritis patients.

What other questions do you have regarding stem cell therapy for pain? If youre ready to learn more about using stem cell therapy to treatyour pain, click the button below to find a pain specialist in your area.

Link:
15 Stem Cell Therapy For Pain Questions, Answered

Posted in Stem Cell Therapy | Comments Off on 15 Stem Cell Therapy For Pain Questions, Answered

Flow Cytometry Core | Lifespan COBRE Center for Stem Cells …

Posted: December 5, 2018 at 4:49 am

The Rhode Island Hospital Stem Cells and Aging (SCA) COBRE Flow Cytometry Core function is to provide high quality, cost effective, state-of-the art flow cytometry and multiparameter cell sorting instrumentation and associated expertise and services to all investigators in the SCA COBRE and to the general research community in Rhode Island.

The core is staffed by Mark Dooner and Loren Fast, PhD

Mark Dooner directs and manages the core and serves as operator for the BD Biosciences Influx cell sorter and LSRII. Dr. Fast serves as co-director and is available as an advisor to the investigators in experimental design and data interpretation. Together they have over 45 years of flow cytometry experience.

The core has had experience with a variety of different flow cytometry applications and protocols and will work with both experienced and novice investigators to help plan and execute successful flow cytometry experiments.

The Rhode Island Flow Cytometry Facility is in the Coro West Building, 5th Floor, Suite 5.08A, One Hoppin Street, Providence.

All first-time users must contact Mark Dooner to discuss their project and to set up a user account. Every effort will be made to accommodate sorting requests in a timely manner. Booking in advance is recommended.

Please note SCA COBRE projects and pilot projects will be given priority.

Contact information:Mark Dooner, COBRE Flow Cytometry Core, Rhode Island Hospitalmdooner@lifespan.orgPhone: 401-444-2463

The sorter separates particles on the detection of fluorescent markers on particles such as cells, chromosomes, bacteria or nuclei.

Then the collected cells are suitable for downstream analysis either in molecular applications like protein assays and PCR, or used in viable assays such as tissue culture or injected into in vivo models.

Generated data may also be used to determine percentages of interrogated populations. The sorter can separate populations into tubes (1.5ml, 4ml, 15ml, 50ml), multi-well plates (6, 24, 48, 96, 384), or directly onto microscope slides.

Excerpt from:
Flow Cytometry Core | Lifespan COBRE Center for Stem Cells ...

Posted in Rhode Island Stem Cells | Comments Off on Flow Cytometry Core | Lifespan COBRE Center for Stem Cells …

Arizona Pain Regenerative Institute – Arizona Pain Specialists

Posted: December 5, 2018 at 4:47 am

The Arizona Pain Regenerative Institute was formed in order to focus on the delivery of this cutting-edge technology in the most safe and effective way for out patients. Stem cells are the future of medicine.

Were here to help shape it. We are experts of pain management and stem cell therapy with a proven track record of success. Pain relief is attainable, we can help you live without pain.

Our double board certified doctors want to help you live pain free. Please call the phone number above to schedule anappointmentand see if stem cell therapy is right for you. Arizona Pain delivers a comprehensive approach to pain management.

We will examine the source of your pain and take thenecessarysteps to give you relief in the best way possible Just as we would for our own mom or dad. AtArizona Pain Specialists we provide hope and restoring life.

Call us now and get your life back today!

More here:
Arizona Pain Regenerative Institute - Arizona Pain Specialists

Posted in Arizona Stem Cells | Comments Off on Arizona Pain Regenerative Institute – Arizona Pain Specialists

Texas | The Stem Cellar

Posted: December 5, 2018 at 4:45 am

Texas Capitol. (Shutterstock)

In 2017 Texas passed a sweeping new law, HB 810, which allowed medical clinics to provide investigational stem cell treatments to patients with certain severe chronic diseases or terminal illnesses. Those in favor of the law argued that patients battling life-threatening or life-changing diseases should have the right to try stem cell therapies that were involved in a clinical trial.

Now a new study, published in the journal Stem Cells and Development, looks at the impact of the law. The report says that despite some recent amendments t there are still some concerns about the law including:

The researchers conclude:

While HB 810 opens up access to patients, it also increases significant risks for their safety and financial cost for something that might have no positive impact on their disease. Truly understanding the impact of stem cell based interventions (SCBI) requires scientific rigor, and accurate outcome data reporting must be pursued to ensure the safety and efficacy behind such procedures. This information must be readily available so that patients can make informed decisions before electing to pursue such treatments. The creation of the SCBI registry could allow for some level of scientific rigor, provide a centralized data source, and offer the potential for better informed patient choices, and might be the best option for the state to help protect patients.

Another CIRM-funded company gets RMAT designation

When Congress approved the 21st Century Cures Act a few years ago one of the new programs it created was the Regenerative Medicine Advanced Therapy (RMAT) designation. This was given to therapies that are designed to treat a serious or life-threatening condition, where early clinical stage trials show the approach is safe and appears to be effective.

Getting an RMAT designation is a big deal. It means the company or researchers are able to apply for an expedited review by the FDA and could get approval for wider use.

This week Poseida Therapeutics was granted RMAT designation by the Food and drug Administration (FDA) for P-BCMA-101, its CAR-T therapy for relapsed/refractory multiple myeloma. This is currently in a Phase 1 clinical trial that CIRM is funding

In this trial Poseidas technology takes an immunotherapy approach that uses the patients own engineered immune system T cells to seek and destroy cancerous myeloma cells.

In a news release Eric Ostertag, Poseidas CEO, welcomed the news:

Initial Phase 1 data presented at the CAR-TCR Summit earlier this year included encouraging response rates and safety data, including meaningful responses in a heavily pretreated population. We expect to have an additional data update by the end of the year and look forward to working closely with the FDA to expedite development of P-BCMA-101.

This means that five CIRM-funded companies have now been granted RMAT designations:

Like Loading...

Read the original post:
Texas | The Stem Cellar

Posted in Texas Stem Cells | Comments Off on Texas | The Stem Cellar

Nick Bostrom – Wikipedia

Posted: December 4, 2018 at 12:45 pm

Nick Bostrom (; Swedish: Niklas Bostrm [bustrm]; born 10 March 1973)[3] is a Swedish philosopher at the University of Oxford known for his work on existential risk, the anthropic principle, human enhancement ethics, superintelligence risks, and the reversal test. In 2011, he founded the Oxford Martin Programme on the Impacts of Future Technology,[4] and he is currently the founding director of the Future of Humanity Institute[5] at Oxford University.

Bostrom is the author of over 200 publications,[6] including Superintelligence: Paths, Dangers, Strategies (2014), a New York Times bestseller[7] and Anthropic Bias: Observation Selection Effects in Science and Philosophy (2002).[8] In 2009 and 2015, he was included in Foreign Policy's Top 100 Global Thinkers list.[9][10] Bostrom believes there are potentially great benefits from Artificial General Intelligence, but warns it might very quickly transform into a Superintelligence that would deliberately extinguish humanity out of precautionary self-preservation or some unfathomable motive, making solving the problems of control beforehand an absolute priority. Although his book on superintelligence was recommended by both Elon Musk and Bill Gates, Bostrom has expressed frustration that the reaction to its thesis typically falls into two camps, one calling his recommendations absurdly alarmist because creation of superintelligence is unfeasible, and the other deeming them futile because superintelligence would be uncontrollable. Bostrom notes that both these lines of reasoning converge on inaction rather than trying to solve the control problem while there may still be time.[11][12]

Born as Niklas Bostrm in 1973[13] in Helsingborg, Sweden,[6] he disliked school at a young age, and he ended up spending his last year of high school learning from home. He sought to educate himself in a wide variety of disciplines, including anthropology, art, literature, and science.[1] Despite what has been called a "serious mien", he once did some turns on London's stand-up comedy circuit.[6]

He holds a B.A. in philosophy, mathematics, logic and artificial intelligence from the University of Gothenburg and master's degrees in philosophy and physics, and computational neuroscience from Stockholm University and King's College London, respectively. During his time at Stockholm University, he researched the relationship between language and reality by studying the analytic philosopher W. V. Quine.[1] In 2000, he was awarded a PhD in philosophy from the London School of Economics. He held a teaching position at Yale University (20002002), and he was a British Academy Postdoctoral Fellow at the University of Oxford (20022005).[8][14]

Aspects of Bostrom's research concern the future of humanity and long-term outcomes.[15][16] He introduced the concept of an existential risk,[1] which he defines as one in which an "adverse outcome would either annihilate Earth-originating intelligent life or permanently and drastically curtail its potential." In the 2008 volume Global Catastrophic Risks, editors Bostrom and Milan irkovi characterize the relation between existential risk and the broader class of global catastrophic risks, and link existential risk to observer selection effects[17] and the Fermi paradox.[18][19]

In 2005, Bostrom founded the Future of Humanity Institute,[1] which researches the far future of human civilization. He is also an adviser to the Centre for the Study of Existential Risk.[16]

In his 2014 book Superintelligence: Paths, Dangers, Strategies, Bostrom reasoned that "the creation of a superintelligent being represents a possible means to the extinction of mankind".[20] Bostrom argues that a computer with near human-level general intellectual ability could initiate an intelligence explosion on a digital time scale with the resultant rapid creation of something so powerful that it might deliberately or accidentally destroy human kind.[21] Bostrom contends the power of a superintelligence would be so great that a task given to it by humans might be taken to open ended extremes, for example a goal of calculating Pi could collaterally cause nanotechnology manufactured facilities to sprout over the entire Earth's surface and cover it within days.[22] He believes an existential risk to humanity from superintelligence would be immediate once brought into being, thus creating an exceedingly difficult problem of finding out how to control such an entity before it actually exists.[21]

Warning that a human-friendly prime directive for AI would rely on the absolute correctness of the human knowledge it was based on, Bostrom points to the lack of agreement among most philosophers as an indication that most philosophers are wrong, with the attendant possibility that a fundamental concept of current science may be incorrect. Bostrom says that there are few precedents to guide an understanding of what pure non-anthropocentric rationality would dictate for a potential Singleton AI being held in quarantine.[23] Noting that both John von Neumann and Bertrand Russell advocated a nuclear strike, or the threat of one, to prevent the Soviets acquiring the atomic bomb, Bostrom says the relatively unlimited means of superintelligence might make for its analysis moving along different lines to the evolved "diminishing returns" assessments that in humans confer a basic aversion to risk.[24] Group selection in predators working by means of cannibalism shows the counter-intuitive nature of non-anthropocentric "evolutionary search" reasoning, and thus humans are ill-equipped to perceive what an artificial intelligence's intentions might be.[25] Accordingly, it cannot be discounted that any Superintelligence would ineluctably pursue an 'all or nothing' offensive action strategy in order to achieve hegemony and assure its survival.[26] Bostrom notes that even current programs have, "like MacGyver", hit on apparently unworkable but functioning hardware solutions, making robust isolation of Superintelligence problematic.[27]

A machine with general intelligence far below human level, but superior mathematical abilities is created.[28] Keeping the AI in isolation from the outside world especially the internet, humans pre-program the AI so it always works from basic principles that will keep it under human control. Other safety measures include the AI being "boxed" (run in a virtual reality simulation), and being used only as an 'oracle' to answer carefully defined questions in a limited reply (to prevent it manipulating humans).[21] A cascade of recursive self-improvement solutions feeds an intelligence explosion in which the AI attains superintelligence in some domains. The super intelligent power of the AI goes beyond human knowledge to discover flaws in the science that underlies its friendly-to-humanity programming, which ceases to work as intended. Purposeful agent-like behavior emerges along with a capacity for self-interested strategic deception. The AI manipulates human beings into implementing modifications to itself that are ostensibly for augmenting its (feigned) modest capabilities, but will actually function to free Superintelligence from its "boxed" isolation.[29]

Employing online humans as paid dupes, and clandestinely hacking computer systems including automated laboratory facilities, the Superintelligence mobilises resources to further a takeover plan. Bostrom emphasises that planning by a Superintelligence will not be so stupid that humans could detect actual weaknesses in it.[30]

Although he canvasses disruption of international economic, political and military stability including hacked nuclear missile launches, Bostrom thinks the most effective and likely means for Superintelligence to use would be a coup de main with weapons several generations more advanced than current state of the art. He suggests nanofactories covertly distributed at undetectable concentrations in every square metre of the globe to produce a worldwide flood of human-killing devices on command.[31][28] Once a Superintelligence has achieved world domination, humankind would be relevant only as resources for the achievement of the AI's objectives ("Human brains, if they contain information relevant to the AIs goals, could be disassembled and scanned, and the extracted data transferred to some more efficient and secure storage format").[32]

In January 2015, Bostrom joined Stephen Hawking among others in signing the Future of Life Institute's open letter warning of the potential dangers of AI.[33] The signatories "...believe that research on how to make AI systems robust and beneficial is both important and timely, and that concrete research should be pursued today."[34] Cutting edge AI researcher Demis Hassabis then met with Hawking, subsequent to which he did not mention "anything inflammatory about AI", which Hassabis, took as 'a win'.[35] Along with Google, Microsoft and various tech firms, Hassabis, Bostrom and Hawking and others subscribed to 23 principles for safe development of AI.[36] Hassabis suggested the main safety measure would be an agreement for whichever AI research team began to make strides toward an artificial general intelligence to halt their project for a complete solution to the control problem prior to proceeding.[37] Bostrom had pointed out that even if the crucial advances require the resources of a state, such a halt by a lead project might be likely to motivate a lagging country to a catch-up crash program or even physical destruction of the project suspected of being on the verge of success.[38]

In 1863 Darwin among the Machines, an essay by Samuel Butler predicted intelligent machines' domination of humanity, but Bostom's suggestion of deliberate massacre of all humankind is the most extreme of such forecasts to date. One journalist wrote in a review that Bostrom's "nihilistic" speculations indicate he "has been reading too much of the science fiction he professes to dislike"[31] As given in his most recent book, From Bacteria to Bach and Back, renowned philosopher Daniel Dennett's views remain in contradistinction to those of Bostrom. [39] Dennett modified his views somewhat after reading The Master Algorithm, and now acknowledges that it is "possible in principle" to create "strong AI" with human-like comprehension and agency, but maintains that the difficulties of any such "strong AI" project as predicated by Bostrom's "alarming" work would be orders of magnitude greater than those raising concerns have realized, and at least 50 years away.[40] Dennett thinks the only relevant danger from AI systems is falling into anthropomorphism instead of challenging or developing human users' powers of comprehension.[41] Since a 2014 book in which he expressed the opinion that artificial intelligence developments would never challenge humans' supremacy, environmentalist James Lovelock has moved far closer to Bostrom's position, and in 2018 Lovelock said that he thought the overthrow of humankind will happen within the foreseeable future.[42][43]

Bostrom has published numerous articles on anthropic reasoning, as well as the book Anthropic Bias: Observation Selection Effects in Science and Philosophy. In the book, he criticizes previous formulations of the anthropic principle, including those of Brandon Carter, John Leslie, John Barrow, and Frank Tipler.[44]

Bostrom believes that the mishandling of indexical information is a common flaw in many areas of inquiry (including cosmology, philosophy, evolution theory, game theory, and quantum physics). He argues that a theory of anthropics is needed to deal with these. He introduces the Self-Sampling Assumption (SSA) and the Self-Indication Assumption (SIA), shows how they lead to different conclusions in a number of cases, and points out that each is affected by paradoxes or counterintuitive implications in certain thought experiments. He suggests that a way forward may involve extending SSA into the Strong Self-Sampling Assumption (SSSA), which replaces "observers" in the SSA definition with "observer-moments".

In later work, he has described the phenomenon of anthropic shadow, an observation selection effect that prevents observers from observing certain kinds of catastrophes in their recent geological and evolutionary past.[45] Catastrophe types that lie in the anthropic shadow are likely to be underestimated unless statistical corrections are made.

Bostrom's simulation argument posits that at least one of the following statements is very likely to be true:[46][47]

The idea has influenced the views of Elon Musk.[48]

Bostrom is favorable towards "human enhancement", or "self-improvement and human perfectibility through the ethical application of science",[49][50] as well as a critic of bio-conservative views.[51]

In 1998, Bostrom co-founded (with David Pearce) the World Transhumanist Association[49] (which has since changed its name to Humanity+). In 2004, he co-founded (with James Hughes) the Institute for Ethics and Emerging Technologies, although he is no longer involved in either of these organisations. Bostrom was named in Foreign Policy's 2009 list of top global thinkers "for accepting no limits on human potential."[52]

With philosopher Toby Ord, he proposed the reversal test. Given humans' irrational status quo bias, how can one distinguish between valid criticisms of proposed changes in a human trait and criticisms merely motivated by resistance to change? The reversal test attempts to do this by asking whether it would be a good thing if the trait was altered in the opposite direction.[53]

He has suggested that technology policy aimed at reducing existential risk should seek to influence the order in which various technological capabilities are attained, proposing the principle of differential technological development. This principle states that we ought to retard the development of dangerous technologies, particularly ones that raise the level of existential risk, and accelerate the development of beneficial technologies, particularly those that protect against the existential risks posed by nature or by other technologies.[54][55]

Bostrom's theory of the Unilateralist's Curse[56] has been cited as a reason for the scientific community to avoid controversial dangerous research such as reanimating pathogens.[57]

Bostrom has provided policy advice and consulted for an extensive range of governments and organisations. He gave evidence to the House of Lords, Select Committee on Digital Skills.[58] He is an advisory board member for the Machine Intelligence Research Institute,[59] Future of Life Institute,[60] Foundational Questions Institute[61] and an external advisor for the Cambridge Centre for the Study of Existential Risk.[62][63]

More here:
Nick Bostrom - Wikipedia

Posted in Transhumanist | Comments Off on Nick Bostrom – Wikipedia

Stem Cell Therapy Phoenix Arizona | Desert Health Specialists

Posted: December 4, 2018 at 12:44 pm

Stem Cell Therapy for Arthritis has 4 different key components

SUPPORTING SOFT TISSUE REPAIR

Extracellular matrix composition of Collagens I, III, IV, V, VII and other structural proteins provides a natural scaffold to facilitate cellular adhesion while assisting cellular migration and proliferation.(1)

PROMOTE SOFT TISSUE RECONSTRUCTION

Growth factors found in amniotic tissue such as PDGF, VEGF, EGF, FGF and TGF-B promote cellular proliferation and new collagen formation and minimize scar tissue formation.(1)

REDUCE INFLAMMATION AND PAIN

Interleukin-1 receptor antagonists (IL-1RA) and Tissue Inhibitor of Metalloproteinase (TIMP) 1, 2, 3, 4 proteins present in amniotic tissues suppress and modulate inflammation and pain.(2)

IMMUNE-PRIVILEGED

Amniotic tissues have been described as immune-privileged because they rarely evoke an immune response in the human body.

References

1. Gruss, J, et al. Human amniotic membrane: a versatile wound dressing. CMA Journal 1978; Vol 118: 1237-1246. Niknejad, H, et al. (Stem Cell Therapy for Arthritis)

2. Properties of amniotic membrane for potential use in Tissue Engineering. European Cells and Materials 2008; Vol 15: 88-99.

Stem Cell Therapy Phoenix Arizona

Read more here:
Stem Cell Therapy Phoenix Arizona | Desert Health Specialists

Posted in Arizona Stem Cells | Comments Off on Stem Cell Therapy Phoenix Arizona | Desert Health Specialists

Page 1,345«..1020..1,3441,3451,3461,347..1,3501,360..»